TELES Informationstechnologien AG (TLIK) - Total Assets
Based on the latest financial reports, TELES Informationstechnologien AG (TLIK) holds total assets worth €4.29 Million EUR (≈ $5.01 Million USD) as of March 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See shareholders equity of TELES Informationstechnologien AG for net asset value and shareholders' equity analysis.
TELES Informationstechnologien AG - Total Assets Trend (2003–2024)
This chart illustrates how TELES Informationstechnologien AG's total assets have evolved over time, based on quarterly financial data.
TELES Informationstechnologien AG - Asset Composition Analysis
Current Asset Composition (December 2024)
TELES Informationstechnologien AG's total assets of €4.29 Million consist of 6.4% current assets and 93.6% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 3.0% |
| Accounts Receivable | €30.65K | 0.7% |
| Inventory | €0.00 | 0.0% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €0.00 | 0.0% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2003–2024)
This chart illustrates how TELES Informationstechnologien AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of TELES Informationstechnologien AG.
Key Asset Composition Facts
- Current vs. Non-Current Assets: TELES Informationstechnologien AG's current assets represent 6.4% of total assets in 2024, a decrease from 78.8% in 2003.
- Cash Position: Cash and equivalents constituted 3.0% of total assets in 2024, down from 58.3% in 2003.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 3.0% in 2003.
- Asset Diversification: The largest asset category is accounts receivable at 0.7% of total assets.
TELES Informationstechnologien AG Competitors by Total Assets
Key competitors of TELES Informationstechnologien AG based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
|
China | CN¥235.37 Billion |
|
Sinopharm Group Co. Ltd
F:X2S
|
Germany | €390.36 Billion |
|
Guangxi Liuzhou Pharm Co Ltd
SHG:603368
|
China | CN¥21.18 Billion |
|
ShareHope Medicine Co Ltd
TWO:8403
|
Taiwan | NT$6.62 Billion |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$8.80 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
TELES Informationstechnologien AG - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.38 | 0.58 | 0.32 |
| Quick Ratio | 0.38 | 0.17 | 0.32 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-430.22K | €-6.04 Million | €-1.19 Million |
TELES Informationstechnologien AG - Advanced Valuation Insights
This section examines the relationship between TELES Informationstechnologien AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 18.15 |
| Latest Market Cap to Assets Ratio | 0.53 |
| Asset Growth Rate (YoY) | -64.7% |
| Total Assets | €4.17 Million |
| Market Capitalization | $2.20 Million USD |
Valuation Analysis
Below Book Valuation: The market values TELES Informationstechnologien AG's assets below their book value (0.53x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: TELES Informationstechnologien AG's assets decreased by 64.7% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for TELES Informationstechnologien AG (2003–2024)
The table below shows the annual total assets of TELES Informationstechnologien AG from 2003 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €4.17 Million ≈ $4.87 Million |
-64.72% |
| 2023-12-31 | €11.81 Million ≈ $13.81 Million |
+563.85% |
| 2022-12-31 | €1.78 Million ≈ $2.08 Million |
-37.51% |
| 2021-12-31 | €2.85 Million ≈ $3.33 Million |
+142.05% |
| 2020-12-31 | €1.18 Million ≈ $1.38 Million |
-57.63% |
| 2019-12-31 | €2.78 Million ≈ $3.25 Million |
+91.79% |
| 2018-12-31 | €1.45 Million ≈ $1.69 Million |
-26.24% |
| 2017-12-31 | €1.96 Million ≈ $2.29 Million |
+63.18% |
| 2016-12-31 | €1.20 Million ≈ $1.41 Million |
-6.82% |
| 2015-12-31 | €1.29 Million ≈ $1.51 Million |
-58.29% |
| 2014-12-31 | €3.10 Million ≈ $3.62 Million |
-30.73% |
| 2013-12-31 | €4.47 Million ≈ $5.22 Million |
-39.47% |
| 2012-12-31 | €7.38 Million ≈ $8.63 Million |
-22.56% |
| 2011-12-31 | €9.53 Million ≈ $11.14 Million |
-25.34% |
| 2010-12-31 | €12.77 Million ≈ $14.92 Million |
-40.85% |
| 2009-12-31 | €21.58 Million ≈ $25.23 Million |
-11.63% |
| 2008-12-31 | €24.42 Million ≈ $28.55 Million |
-71.03% |
| 2007-12-31 | €84.31 Million ≈ $98.57 Million |
-38.63% |
| 2006-12-31 | €137.38 Million ≈ $160.61 Million |
-14.76% |
| 2005-12-31 | €161.17 Million ≈ $188.42 Million |
+79.56% |
| 2004-12-31 | €89.76 Million ≈ $104.94 Million |
+3.68% |
| 2003-12-31 | €86.57 Million ≈ $101.21 Million |
-- |
About TELES Informationstechnologien AG
Arzneiwerk AG VIDA engages in the supply of pharmaceuticals for newly developed or rare medicines in Europe. The company was formerly known as TELES Aktiengesellschaft and changed its name to Arzneiwerk AG VIDA in July 2024. The company was incorporated in 1996 and is based in Berlin, Germany.